Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,223.63 +51.48 (+0.63%) Bitcoin USD
61,565.34 +3,160.00 (+5.41%) CMC Crypto 200
1,327.09 +50.11 (+3.93%)
AnaptysBio, Inc. (ANAB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:20AM EDT. Market open.
| Previous close | 26.34 |
| Open | 26.76 |
| Bid | 26.00 x 100 |
| Ask | 26.37 x 200 |
| Day's range | 26.12 - 27.02 |
| 52-week range | 13.36 - 27.50 |
| Volume | |
| Avg. volume | 360,767 |
| Market cap | 713.562M |
| Beta (5Y monthly) | -0.29 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
AnaptysBio (ANAB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
AnaptysBio (ANAB) Soars 14.3%: Is Further Upside Left in the Stock?
AnaptysBio (ANAB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
- Zacks
Why You Shouldn't Bet Against AnaptysBio (ANAB) Stock.
AnaptysBio (ANAB) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
© 2024 Yahoo. All rights reserved.